Last reviewed · How we verify

Enzira® vaccine — Competitive Intelligence Brief

Enzira® vaccine (Enzira® vaccine) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Inactivated influenza vaccine. Area: Immunology / Infectious Disease.

marketed Inactivated influenza vaccine Immunology / Infectious Disease Biologic Live · refreshed every 30 min

Target snapshot

Enzira® vaccine (Enzira® vaccine) — Seqirus. Enzira is an inactivated influenza vaccine that stimulates the immune system to produce antibodies against influenza virus strains.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Enzira® vaccine TARGET Enzira® vaccine Seqirus marketed Inactivated influenza vaccine
High-Dose Influenza Vaccine High-Dose Influenza Vaccine Saad Jamshed MD marketed Inactivated influenza vaccine
Vaxigrip® Vaxigrip® National University Hospital, Singapore marketed Inactivated influenza vaccine
inactivated split-virus influenza vaccine inactivated split-virus influenza vaccine The Cleveland Clinic marketed inactivated influenza vaccine
SP Shz TIV SP Shz TIV Sanofi marketed Inactivated influenza vaccine
Hualan TIV Hualan TIV Sanofi marketed Inactivated influenza vaccine
ccIIV4 ccIIV4 Vanderbilt University Medical Center marketed Inactivated influenza vaccine

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Inactivated influenza vaccine class)

  1. GlaxoSmithKline · 16 drugs in this class
  2. Seqirus · 5 drugs in this class
  3. Sanofi Pasteur, a Sanofi Company · 5 drugs in this class
  4. Green Cross Corporation · 4 drugs in this class
  5. Novartis · 2 drugs in this class
  6. SK Chemicals Co., Ltd. · 2 drugs in this class
  7. Sanofi · 2 drugs in this class
  8. Hospital Israelita Albert Einstein · 2 drugs in this class
  9. McGill University Health Centre/Research Institute of the McGill University Health Centre · 2 drugs in this class
  10. Il-Yang Pharm. Co., Ltd. · 2 drugs in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Enzira® vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/enzira-vaccine. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: